SUNNYVALE, Calif.,
Dec. 14, 2017 /PRNewswire/ -- Accuray Incorporated
(NASDAQ: ARAY) announced today that the Heidelberg University
Hospital in Heidelberg, Germany
and Oscar Lambret Cancer Center in Lille,
France are the first in the world to connect both their
Accuray CyberKnife® and TomoTherapy®
platforms to the iDMS™ Data Management System. The two facilities
are now able to benefit from a centralized database that shares and
makes data accessible across the radiation therapy treatment
delivery platforms, adding flexibility and improving efficiency in
their radiation therapy departments.
The iDMS System allows for the seamless integration of a wide
range of technologies including the Radixact™,
TomoTherapy and CyberKnife Systems, Accuray Precision™
Treatment Planning System (TPS), and third-party treatment planning
and oncology information systems (OIS). As a result, clinicians can
leverage the technology and data they need to optimize each patient
treatment.
"Heidelberg is an extremely busy hospital, treating more than
4,500 cancer patients per year. We require radiation therapy
technology that can keep pace with the demands of our facility and
enable us to deliver precise radiation to any tumor in the shortest
amount of time possible," said Jürgen Peter
Debus, M.D., Ph.D, Medical Director of the Department of
Radiation Oncology and Radiation Therapy at Heidelberg University
Hospital. "The integration of the Accuray radiation therapy and
treatment planning systems with the iDMS System helps us do just
that. Treatment planning is now faster, reducing overall treatment
time, without sacrificing quality and we can easily transfer
patients between systems so we don't risk downtime."
iDMS System Integration Benefits
The centralized
platform for storing and managing all patient and treatment plan
data provides the clinical team with numerous benefits
including:
- Seamless treatment of patients on different compatible Accuray
delivery systems while maintaining a single treatment record,
simplifying and personalizing patient treatment
- Quick access to previously treated patient files, reducing
treatment time
- Remote review and authorization of treatment plans with
PlanTouch™, enhancing flexibility
- Interfaces with compatible third-party OIS, providing efficient
department integration
- Customizable generation of patient, plan and system reports,
supporting practice needs
- State-of-the-art disaster recovery features, ensuring data
integrity
"Radiotherapy is a key component of our multidisciplinary
approach to treating cancer. With the installation of the iDMS Data
Management System we have the flexibility to treat patients using
either our TomoTherapy Systems or our new CyberKnife M6™
System, while maintaining one patient record. This simplifies and
speeds up the entire treatment process, while enabling us to adapt
how we choose to deliver the radiation treatment at each session
based on the needs of the patient," said Xavier Mirabel, M.D., Head of the Department of
Radiation Oncology and Brachytherapy, Oscar Lambret Cancer
Center.
"One of our main goals in developing the iDMS™ System
was to create an exceptional patient treatment delivery experience.
The real-world results shared by the Heidelberg and Lille teams demonstrate we are on our way to
achieving this goal," said Lionel Hadjadjeba, M.D., Senior Vice
President and Chief Commercial Officer at Accuray. "By providing
customers with a single point of control for managing multiple,
different Accuray radiation therapy platforms, and the seamless
connection of systems and data, we are making it easier to provide
patients with the best possible treatment at each stage of their
cancer treatment journey."
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company
that develops, manufactures, and sells precise, innovative tumor
treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The company's
leading-edge technologies deliver the full range of radiation
therapy and radiosurgery treatments. For more information, please
visit www.accuray.com
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited, to the ability of the iDMS
System to improve treatment outcomes, increase efficiencies and
reduce treatment time, clinical applications, market acceptance of
our new technologies, and Accuray's leadership position in
radiation oncology innovation and technologies. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ materially from expectations, including
but not limited to the risks detailed from time to time under the
heading "Risk Factors" in the company's annual report on Form 10-K,
and as updated periodically with the company's other filings with
the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to
Accuray at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Media Contacts:
Beth Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
Marisa Borgasano
MSLGROUP
+1 (781) 684-0770
accuray@mslgroup.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/first-hospitals-in-the-world-achieve-inter-system-connectivity-across-accuray-radiation-therapy-platforms-300571165.html
SOURCE Accuray Incorporated